Matinas BioPharma (MTNB)

• Market cap: $3.75M
• 1 day: 0.17%
• 5 days: -13.82%
• 1 month: -24.78%
• 3 months: -68.99%
• 6 months: -34.16%
• Year to date: -0.34%
• 1 year: 14.9%
• 5 years: -99.14%
• 10 years: -99.7%
• Sector: Healthcare
• Industry: Drug Manufacturers - General

About: Matinas BioPharma Holdings Inc is a clinical-stage biopharmaceutical company with a focus on identifying and developing novel pharmaceutical products. The firm's pipeline includes MAT2203, MAT2501, and others.

Employees: 34